This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Health Research, Inc.. Active years: 2005-2010.
Company Filing History:
Years Active: 2005-2010
Title: Youcef M Rustum: Innovator in Cancer Therapy and Treatment
Introduction
Youcef M Rustum is a notable inventor based in Amherst, NY (US), recognized for his contributions to cancer therapy and treatment. With a total of 3 patents, Rustum has developed innovative methods that aim to improve the efficacy of cancer treatments and reduce associated side effects.
Latest Patents
One of Rustum's latest patents is a method for optimizing cancer therapy by monitoring the maturation of tumor-associated vasculature using selenium. This invention provides a systematic approach for administering chemotherapeutic agents by first administering a selenium compound to an individual. The method involves monitoring the modulation of tumor vessel maturation (TVM) to identify the optimal timing for chemotherapy administration. Additionally, this invention offers a way to determine if a tumor is likely to respond to chemotherapy based on the observed increase in TVM after selenium administration.
Another significant patent by Rustum is focused on reducing alopecia and bladder toxicity associated with the anti-cancer agent cyclophosphamide. This method involves administering cyclophosphamide alongside a selenium compound to individuals in need of treatment. The selenium compounds can be given before, during, or after the administration of cyclophosphamide, thereby mitigating its adverse effects.
Career Highlights
Rustum's work has been instrumental in advancing cancer treatment methodologies. His innovative approaches have the potential to enhance patient outcomes and improve the quality of life for those undergoing chemotherapy.
Collaborations
Rustum has collaborated with notable colleagues, including Karoly Toth and Harry K Slocum, contributing to the development of his groundbreaking inventions.
Conclusion
Youcef M Rustum's contributions to cancer therapy through his innovative patents demonstrate his commitment to improving treatment outcomes for patients. His work continues to pave the way for advancements in the field of oncology.